SCHEMBL9765796

SCHEMBL9765796

CCOC(=O)C1=C(C)NC(C)=C(C(=O)O)C1c1cccnc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 2/20 0.73
TSHR P16473 4/20 0.65
NPSR1 Q6W5P4 1/20 0.65
MAPT P10636 1/20 0.64
MAPK1 P28482 1/20 0.64
KDM4E B2RXH2 5/20 0.62
ALDH1A1 P00352 5/20 0.62
GAA P10253 4/20 0.62
HSD17B10 Q99714 3/20 0.62
HPGD P15428 3/20 0.62
CASP1 P29466 2/20 0.62
CASP7 P55210 1/20 0.62
ADORA3 P0DMS8 2/20 0.62
PKM P14618 1/20 0.61
ACHE P22303 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.55
CACNA1F O60840 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7159081 0.95 TSHR (0.70) CACNA1BTSHRNPSR1MAPTMAPK1
SCHEMBL7161996 0.90 ADORA3 (0.73) CACNA1BTSHRNPSR1MAPTMAPK1
SCHEMBL11868720 0.90 TSHR (0.65) CACNA1BTSHRNPSR1MAPTMAPK1
SCHEMBL9401812 0.88 CACNA1B (0.65) CACNA1BTSHRNPSR1MAPTMAPK1
SCHEMBL11877364 0.88 TSHR (0.65) CACNA1BTSHRNPSR1MAPTMAPK1
SCHEMBL7162770 0.88 CACNA1B (0.66) CACNA1BTSHRNPSR1MAPTMAPK1
SCHEMBL1665260 0.86 MAPT (0.68) CACNA1BTSHRNPSR1MAPTMAPK1
SCHEMBL11521974 0.86 TSHR (0.62) CACNA1BTSHRNPSR1MAPTMAPK1
SCHEMBL29173863 0.86 ADORA3 (0.82) CACNA1BTSHRMAPTKDM4EALDH1A1
SCHEMBL27541937 0.86 CACNA1B (0.67) CACNA1BTSHRNPSR1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0127150-A2 2,6-Disubstituted-1,4-dihydropyridine derivative, process for the preparation of the same and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-12-05 EP claimed
US-4988717-A Optically active 1,4-dihydropyridine esters useful for treating circulatory illnesses BAYER AKTIENGESELLSCHAFT (DE) 1991-01-29 US disclosed
US-4849433-A The compound, (⃡)1,4-dihydro-2,6-dimethyl-4-(2'-nitrophenyl)-pyridine-3,5-dicarboxylic acid, methyl isobutyl ester, compositions containing same and a method for effecting coronary dilation BAYER AKTIENGESELLSCHAFT (DE) 1989-07-18 US disclosed
US-4579859-A HYPOTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-01 US disclosed
US-4510310-A 1,4-Dihydro-2,6-dimethyl-4-(2'-chlorophenyl)-3,5-dicarboxylic acid,methyl or ethyl,trifluoroethyl ester BAYER AKTIENGESELLSCHAFT (DE) 1985-04-09 US disclosed
EP-0127150-A2 2,6-Disubstituted-1,4-dihydropyridine derivative, process for the preparation of the same and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-12-05 EP disclosed